FDA Inspection 1199722 — Louise M Thurman/IPS Research Company
The FDA completed an inspection of Louise M Thurman/IPS Research Company on March 8, 2023 in Oklahoma City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 8, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Oklahoma City, OK (United States)
Additional Details
Clinical Investigator (CI)